These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24349199)

  • 1. A prognostic gene signature for metastasis-free survival of triple negative breast cancer patients.
    Lee U; Frankenberger C; Yun J; Bevilacqua E; Caldas C; Chin SF; Rueda OM; Reinitz J; Rosner MR
    PLoS One; 2013; 8(12):e82125. PubMed ID: 24349199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions.
    Lee J; Lee J; Farquhar KS; Yun J; Frankenberger CA; Bevilacqua E; Yeung K; Kim EJ; Balázsi G; Rosner MR
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):E364-73. PubMed ID: 24395801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer.
    Yun J; Frankenberger CA; Kuo WL; Boelens MC; Eves EM; Cheng N; Liang H; Li WH; Ishwaran H; Minn AJ; Rosner MR
    EMBO J; 2011 Aug; 30(21):4500-14. PubMed ID: 21873975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A subgroup of microRNAs defines PTEN-deficient, triple-negative breast cancer patients with poorest prognosis and alterations in RB1, MYC, and Wnt signaling.
    Wang DY; Gendoo DMA; Ben-David Y; Woodgett JR; Zacksenhaus E
    Breast Cancer Res; 2019 Jan; 21(1):18. PubMed ID: 30704524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic regulation of invasion by STAT3 in triple negative breast cancer.
    McDaniel JM; Varley KE; Gertz J; Savic DS; Roberts BS; Bailey SK; Shevde LA; Ramaker RC; Lasseigne BN; Kirby MK; Newberry KM; Partridge EC; Jones AL; Boone B; Levy SE; Oliver PG; Sexton KC; Grizzle WE; Forero A; Buchsbaum DJ; Cooper SJ; Myers RM
    Oncotarget; 2017 Jan; 8(5):8226-8238. PubMed ID: 28030809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.
    Liu NQ; Stingl C; Look MP; Smid M; Braakman RB; De Marchi T; Sieuwerts AM; Span PN; Sweep FC; Linderholm BK; Mangia A; Paradiso A; Dirix LY; Van Laere SJ; Luider TM; Martens JW; Foekens JA; Umar A
    J Natl Cancer Inst; 2014 Feb; 106(2):djt376. PubMed ID: 24399849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.
    Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D
    Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum microRNA signature predicts tumor relapse and survival in triple-negative breast cancer patients.
    Kleivi Sahlberg K; Bottai G; Naume B; Burwinkel B; Calin GA; Børresen-Dale AL; Santarpia L
    Clin Cancer Res; 2015 Mar; 21(5):1207-14. PubMed ID: 25547678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis.
    Wushou A; Jiang YZ; Hou J; Liu YR; Guo XM; Shao ZM
    Breast Cancer Res Treat; 2015 Nov; 154(1):57-62. PubMed ID: 26476726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2.
    Sun M; Gomes S; Chen P; Frankenberger CA; Sankarasharma D; Chung CH; Chada KK; Rosner MR
    Oncogene; 2014 Jul; 33(27):3528-37. PubMed ID: 23975428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALAT1 and BACH1 are prognostic biomarkers for triple-negative breast cancer.
    Ou X; Gao G; Bazhabayi M; Zhang K; Liu F; Xiao X
    J Cancer Res Ther; 2019; 15(7):1597-1602. PubMed ID: 31939443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic two-gene signature for triple negative breast cancer.
    Alsaleem MA; Ball G; Toss MS; Raafat S; Aleskandarany M; Joseph C; Ogden A; Bhattarai S; Rida PCG; Khani F; Davis M; Elemento O; Aneja R; Ellis IO; Green A; Mongan NP; Rakha E
    Mod Pathol; 2020 Nov; 33(11):2208-2220. PubMed ID: 32404959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.
    Frankenberger C; Rabe D; Bainer R; Sankarasharma D; Chada K; Krausz T; Gilad Y; Becker L; Rosner MR
    Cancer Res; 2015 Oct; 75(19):4063-73. PubMed ID: 26238785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
    Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
    Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A seven-gene signature can predict distant recurrence in patients with triple-negative breast cancers who receive adjuvant chemotherapy following surgery.
    Park YH; Jung HH; Do IG; Cho EY; Sohn I; Jung SH; Kil WH; Kim SW; Lee JE; Nam SJ; Ahn JS; Im YH
    Int J Cancer; 2015 Apr; 136(8):1976-84. PubMed ID: 25537444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.
    Al-Mulla F; Marafie M; Zea Tan T; Paul Thiery J
    J Cell Biochem; 2014 Mar; 115(3):488-97. PubMed ID: 24123286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers.
    Liu Y; Teng L; Fu S; Wang G; Li Z; Ding C; Wang H; Bi L
    BMC Cancer; 2021 May; 21(1):644. PubMed ID: 34053447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers.
    Gasparini P; Cascione L; Fassan M; Lovat F; Guler G; Balci S; Irkkan C; Morrison C; Croce CM; Shapiro CL; Huebner K
    Oncotarget; 2014 Mar; 5(5):1174-84. PubMed ID: 24632568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.